Plasma Pen for Hooded Eyelids: What Plaxel+ Does and What It Cannot Replace

Plasma pen treatment attracts a particular kind of enquiry. Someone has been told, usually online, that it is a non-surgical alternative to an eyelid operation, and they want to know whether it works. The answer is more interesting than yes or no, because the treatment does something real and specific, and the gap between what it does and what people have been led to expect is where the disappointment lives.

This is a guide to the mechanism, the recovery, and the published evidence, written so that anyone considering it can decide before booking rather than after.

What a plasma arc does to the skin

Plaxel+ is a plasma device. A fine probe is held a fraction above the skin without touching it, and the voltage difference ionises the air in the gap, producing a small electrical arc. That arc delivers thermal energy to a precise point on the skin surface, creating a controlled micro-injury roughly the size of a pinpoint.

Two things happen as a result. The tissue immediately around each point contracts, which produces a visible tightening effect on the day. Then, over the following weeks, the healing response to those micro-injuries drives collagen remodelling in the treated area, which is the slower and more durable part of the change.

The pattern of points is what makes it useful on the upper eyelid. A grid of contractions across a small area of loose skin shortens that skin, and because the arc never touches the skin and the points are separated by untreated tissue, the effect can be placed on areas where more aggressive resurfacing would be difficult. At this clinic it is used for upper eyelid hooding, fine lines around the mouth, crow’s feet, and selected stretch marks and scars.

The distinction that matters: nothing is removed. Surgery for excess eyelid skin removes tissue. Plasma treatment shortens the tissue that is there by injuring and contracting it. Those are different operations on the same anatomy, and they do not produce the same amount of change.

The week you need to plan for

This is the part most enquiries have not accounted for, and it is the reason the treatment suits some people’s lives and not others.

Each point where the arc landed becomes a small dark crust within hours. The treated area is covered in a visible grid of them. They stay for roughly five to seven days and then lift away on their own. Around the eyes, expect to look like you have had something done for the better part of a week.

The rules during that period are short and not negotiable. Do not pick at the crusts. Keep the area dry as instructed. Follow the wound-care guidance you are given. Protect the area from sun exposure rigorously, because skin that is regenerating after a controlled injury is at its most vulnerable to pigment change.

Initial tightening is visible as the crusts clear. The fuller remodelling develops over roughly two to six weeks. Some areas respond after a single treatment and others do better with a second, which is discussed at consultation rather than assumed.

Book it when you have a quiet stretch afterwards. Booking it the week before an event is the single most common planning mistake with this treatment.

What the published evidence shows

The evidence base for plasma treatment of the upper eyelid is small. It consists of observational studies, case series and small trials rather than large randomised comparisons, and anyone presenting it as settled is overstating it. Two studies are worth reading in full.

Evaluation of plasma exeresis as a new technique for non surgical treatment of dermatochalasis (Hassan and colleagues, Journal of Dermatological Treatment, 2022) treated 40 patients with three monthly sessions. Its conclusion was that plasma exeresis “seems to improve appearance of the upper eyelid, without any serious adverse events and could be a valid solution for dermatochalasis especially in mild and moderate cases”. Note the qualifier on severity. It is doing a lot of work.

Upper eyelid blepharoplasty using plasma exeresis: Evaluation of outcomes, satisfaction, and symptoms after procedure (Ferreira and colleagues, Journal of Cosmetic Dermatology, 2021) followed 16 patients and reached a more reserved conclusion: the treatment was minimally invasive with low impact on quality of life, but “overall patient satisfaction is questionable when considering less willing of undergoing procedure again and decreased expectation with results over postoperative period”.

Read together, those two findings describe the treatment accurately. It produces a measurable improvement in mild to moderate eyelid hooding without serious adverse events, and a meaningful proportion of people find the result less than they hoped for once the initial effect settles. Both of those things are true at once, and a consultation that mentions only the first is not preparing anyone properly.

Where it is not a substitute

Plasma treatment is a non-surgical option for selected concerns. It is not equivalent to surgical correction, and we do not present it as one.

Where eyelid hooding is significant, where skin rests on the lashes, or where the visual field is affected, the appropriate conversation is a medical one about surgical assessment, not a cosmetic treatment. That is a referral, and it is a better answer than a course of treatments that will not reach the problem.

Where the concern is the quality and texture of skin over a wider area rather than localised laxity, SkinPen microneedling covers a larger field with less downtime and is usually the better starting point. Where the concern is volume loss rather than excess skin, neither treatment addresses it and the guide to skin laxity sets out how the causes differ.

Skin type changes the risk

This is the most important suitability question and it is not evenly distributed.

Plasma treatment works by causing a controlled thermal injury. Any thermal injury to skin carries a risk of post-inflammatory hyperpigmentation, where the healing area darkens, and that risk rises with Fitzpatrick skin type. In darker skin types the clinic advises caution and assesses case by case, because the treatment leaves a grid of injury points and pigment change following that grid is a poor outcome that can take a long time to settle.

Recent sun exposure raises the same risk and is a reason to postpone rather than proceed. A tan is not a neutral starting point for this treatment.

Who should not have it

• Anyone with a tendency to keloid or hypertrophic scarring. The treatment works by deliberate injury, and a scarring tendency is a reason not to create dozens of small ones.
• Anyone with recent sun exposure to the area, or an active tan.
• Anyone who is pregnant.
• Anyone who cannot commit to the aftercare, particularly leaving the crusts undisturbed and maintaining strict sun protection.
• Anyone who needs to look normal within the next fortnight.

Suitability is confirmed at consultation, and where a darker Fitzpatrick type, a scarring history or recent sun exposure is present, the conversation starts with whether to treat at all rather than with which area.

Booking

Plasma Pen (Plaxel+) starts from £70 and the treatment page carries the current price and the booking link. Treatment is consultation-led, and the consultation is where the area, the number of sessions and the suitability question are settled.

The clinic is at 65 London Road, Newark-on-Trent, NG24 1RZ, with free parking at the front. Patients travel to us from Balderton, Farndon, Collingham, Southwell, Bingham and Ollerton, and from Lincoln, Grantham and Sleaford.

Frequently asked questions